Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Eccentric calcium has challenged current modalities’ ability to adequately modify calcium due to several device-dependent factors. NC balloons often expand the healthy, non-calcified side of the artery, while high pressure or cutting balloons may result in disruption or dissection of healthy intima. Even atherectomy devices are limited due to wire bias that may often result in nonuniform ablation of calcium leaving the calcified plaque untouched.
Topics: Coronary IVL, Coronary Cases, Shockwave C2, CAD Applications - Eccentric Lesions, Coronary IVL - U.S.
Dr. Evan Shlofmitz, DO, Director of Intravascular Imaging, St. Francis Hospital - The Heart Center, Roslyn, New York shares with us his extensive experience with imaging modalities and how the use of intravascular imaging helped create treatment algorithms at St. Francis Hospital to decide on the appropriate calcium modification tool. He also speaks about his experience with Coronary IVL, its safety and the use of OCT to enhance our ability to use intravascular lithotripsy, including case selection and ensuring adequate outcomes.
Topics: Coronary IVL, Coronary Cases, Shockwave C2, Coronary IVL - U.S., Calcium Corner
Introducing The Calcium Corner
Topics: Coronary IVL, Coronary Cases, Shockwave C2, Coronary IVL - U.S., Calcium Corner
Shockwave has been making waves this summer! As you dive into this edition of the PulsePoint Newsletter, you’ll see that JACC: Cardiovascular Interventions published a trilogy of peer-reviewed publications highlighting Shockwave’s MOA, a pooled analysis of the 4 Disrupt CAD studies, and Disrupt PAD lll. Dive deeper and you’ll discover the incredible 10-webinar series called Calcium Masterclass that was launched at the beginning of the quarter. Explore how Shockwave was granted transitional pass-through reimbursement for Coronary IVL and proposed additional payment for hospital in-patient Coronary IVL cases performed in the United States. This PulsePoint has a lot to cover – recap the rest of the events and milestones from an exciting last quarter. But as you relax on your vacation, always stay on the pulse!
Topics: Coronary IVL, IVL Case, Peripheral IVL, IVL Technology, Coronary Cases, Peripheral Cases, Shockwave C2, Shockwave M5, Shockwave S4, PulsePoint Newsletter, Coronary IVL - U.S.
Treatment of nodular calcium in coronary PCI remains a challenge, even for the most skilled operators. Recently, CRT 2021 Virtual featured a live case from Medstar Washington Hospital Center in Washington, DC with nodular calcium from operators Hayder D. Hashim, MD, and Lowell F. Satler, MD, who were joined by an expert panel led by Ron Waksman, MD. During the case the physicians discussed and debated treatment strategies to address nodular calcium, deciding in this case for coronary IVL, which resulted from a baseline MLA of 1.6mm2 to a post-IVL MLA of 4.9mm2 to a post-DES MSA of 7.2mm2.
Topics: Coronary IVL, Coronary Cases, Shockwave C2, CAD Applications - Eccentric Lesions, CAD Applications - Bifurcations, Coronary IVL - U.S.
If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Topics: Medical Meetings, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Topics: Coronary IVL, IVL Case, Peripheral IVL, IVL Technology, Coronary Cases, Peripheral Cases, Shockwave C2, Shockwave M5, Shockwave S4, PulsePoint Newsletter, Coronary IVL - U.S.
We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics Program, The Christ Hospital Health System. Dr. Riley is the leading author of the abstract for the Patient-Level Pooled Analysis of the Disrupt CAD I, II, III and IV studies and presented at ACC.21 Virtual.
Topics: Coronary IVL, DISRUPT CAD, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences
You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Topics: Medical Meetings, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences
One cannot become a calcium expert overnight – it takes time and commitment to go deep on the topic. That’s why we’re excited to embark this month on a year-long education journey that we’re calling the Calcium Masterclass. Over the last year, we’ve been working with Prof. James Spratt (St. George’s University, London) and the team at Optima Education to develop a comprehensive collection of 10 webinars, 5 of which will feature live cases, and a 14-chapter calcium compendium that will be presented by 37 masters of coronary calcium.
Topics: Coronary IVL, Coronary Cases, Shockwave C2, CAD Applications - Eccentric Lesions, CAD Applications - Bifurcations, Coronary IVL - U.S.
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
